Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Kaufman

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2019
Roundtable: How I treat a newly diagnosed patient with high-risk myelomaJonathan L Kaufman
Blood|January 2, 2025
Solvitur ambulandoJonathan L Kaufman
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2012
Toxicities of mobilized stem cell infusionJonathan L Kaufman
Leukemia & Lymphoma|February 18, 2011
Putting the E (evidence) in a new Era for myelomaJonathan L Kaufman, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
The era of combination therapy in myelomaSagar Lonial, Jonathan L Kaufman
Onkologie|April 8, 2006
Proteasome inhibition: novel therapy for multiple myelomaJonathan L Kaufman, Sagar Lonial
Oncology (Williston Park, N.Y.)|November 29, 2013
Non-secretory myeloma: a clinician's guideSagar Lonial, Jonathan L Kaufman
Oncology (Williston Park, N.Y.)|January 17, 2017
Insights Into the Appropriate Use of New Antimyeloma TherapiesJonathan L Kaufman, Sagar Lonial
Current Hematologic Malignancy Reports|June 29, 2018
Novel Approaches for the Management of AL AmyloidosisNisha S Joseph, Jonathan L Kaufman
Hematology. American Society of Hematology. Education Program|December 5, 2025
What is the best induction for myeloma for the fit patient?Nishi Nilesh Shah, Jonathan L Kaufman
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Hematology. American Society of Hematology. Education Program|December 7, 2019
Roundtable: How I treat a newly diagnosed patient with high-risk myelomaJonathan L Kaufman
Blood|January 2, 2025
Solvitur ambulandoJonathan L Kaufman
Methods in Molecular Biology (Clifton, N.J.)|August 15, 2012
Toxicities of mobilized stem cell infusionJonathan L Kaufman
Leukemia & Lymphoma|February 18, 2011
Putting the E (evidence) in a new Era for myelomaJonathan L Kaufman, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
The era of combination therapy in myelomaSagar Lonial, Jonathan L Kaufman
Onkologie|April 8, 2006
Proteasome inhibition: novel therapy for multiple myelomaJonathan L Kaufman, Sagar Lonial
Oncology (Williston Park, N.Y.)|November 29, 2013
Non-secretory myeloma: a clinician's guideSagar Lonial, Jonathan L Kaufman
Oncology (Williston Park, N.Y.)|January 17, 2017
Insights Into the Appropriate Use of New Antimyeloma TherapiesJonathan L Kaufman, Sagar Lonial
Current Hematologic Malignancy Reports|June 29, 2018
Novel Approaches for the Management of AL AmyloidosisNisha S Joseph, Jonathan L Kaufman
Hematology. American Society of Hematology. Education Program|December 5, 2025
What is the best induction for myeloma for the fit patient?Nishi Nilesh Shah, Jonathan L Kaufman
Pageof 15